Navigation Links
BNA Books Announces the Publication of the 2011 Supplement to "Pharmaceutical Patent Law, Second Edition"

ARLINGTON, Va., Dec. 27, 2011 /PRNewswire-USNewswire/ -- BNA Books, a division of specialized news and information publisher BNA, today announces the publication of the 2011 Supplement to Pharmaceutical Patent Law, Second Edition, discussing domestic and international developments in pharmaceutical patent law.


Pharmaceutical Patent Law, Second Edition tracks legal developments within the PTO, the FDA, Congress, the courts, the FTC, the Department of Justice, and the WTO; examines how these agencies and organizations interact with each other; and determines how developments impact strategies within a practitioner's core area of expertise. This treatise is the only reference available with a detailed, practitioner-oriented treatment of pharmaceutical patent law from the perspective of both patent law and food and drug laws.

Pharmaceutical Patent Law also provides complete coverage of advanced topics, including the antitrust implications of patent settlements, the experimental use privilege, and international aspects of the field. Core topics covered include: follow-on biologics, a relatively new field; the substance and procedure of pharmaceutical patent acquisition; FDA marketing approval procedures for innovative and generic drugs; the FDA's Orange Book; patent term extension standards; FDA marketing exclusivities; the scope of patent rights; patent infringement procedures under the Hatch-Waxman Act; and defenses to and remedies for patent infringement.

The all-new 2011 Supplement includes: 

  • A brand-new section on post-marketing activity
  • A new section amplifying international and comparative data protection law, discussing and comparing European supplementary protection certificates and other data protection efforts around the world
  • Discussion of implications for pharmaceutical patent practice of the Leahy-Smith America Invents Act
  • Discussion of the experimental use privilege and postapproval activities
  • Analysis of the multiple 30-month stays under the MMA
  • Discussion of the new FTC report on authorized generics
  • Discussion of patent eligibility following In re Bilski 
  • Analysis of the FDA labeling practice and induced infringement

Pharmaceutical Patent Law, Second Edition, 2011 Supplement is authored by John R. Thomas, a member of the faculty of Georgetown University Law Center, Washington, DC, where he teaches courses in both patent and food and drug law.

BNA, a wholly-owned subsidiary of Bloomberg L.P., is a leading source of legal, regulatory, and business information for professionals. In addition to Pharmaceutical Patent Law, BNA's Book Division publishes: Patents and the Federal Circuit; Patent, Trademark, and Copyright Laws; Patent Litigation Strategies Handbook; Patent Prosecution: Law, Practice, and Procedure; and other titles in intellectual property law. For a free BNA Books catalog, call 1.800.960.1220, send an e-mail request to, or visit us online at

Pharmaceutical Patent Law, Second Edition, 2011 Supplement may be purchased alone (Order #1984-PR11/$235.00 plus tax, shipping, and handling) or with the main volume (860 pp. Hardcover/Order #9984-PR11/$525.00 plus tax, shipping, and handling) from BNA Books, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1.800.960.1220. Fax orders: 1.732.346.1624. A 10% discount is available on print copies of books when ordering from the website at Please note that discounts cannot be combined.

Editors: Review copy available upon request.
Please e-mail Matt Greene at, or call 703.341.5767.


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Announces New 2012 Frontlist eBooks Collection on SciVerse ScienceDirect Available for Advance Purchase
2. Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center
3. Cookstr Launches New Digital Recipe Collections Exclusively on Apples iBookstore
4. Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain
5. Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books
6. BNA Books Announces Publication of New 2009 Cumulative Supplement to Pharmaceutical Law: Regulation of Research, Development, and Marketing
7. Neurobiological Technologies Announces Filing of Certificate of Dissolution and Closing of Stock Transfer Books
8. Novus Scientific Announces a New U.S. Patent for a Mesh Implant Comprising Two Different Resorbable Materials with Different Degradation Times and Specific Mechanical Behaviours; U.S. Patent No. -- 8,083,755
9. Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy
10. Perrigo Announces FDA Final Approval for Desloratadine
11. Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
Breaking Medicine Technology:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):